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Abstract The cDNA of the peroxisomal membrane protein-1-
like protein (PXMP1-L, synonyms: PMP69, P70R), a novel
peroxisomal ATP binding cassette transporter of yet unknown
function, has recently been cloned. The best known peroxisomal
member of this protein family is the adrenoleukodystrophy
protein, defects of which are the underlying cause of X-linked
adrenoleukodystrophy (X-ALD). Here we describe the complete
exon-intron structure (19 exons and 18 introns covering 16.0 kb)
of the human PXMP1-L gene, transcript variants, the localiza-
tion on chromosome 14q24 by cytogenetic analysis and sequen-
cing of the putative promoter region. PXMP1-L has been
proposed to play a role as a modifier in determining the
phenotypic variations observed in X-ALD. The data presented
will enable sequence analysis of the PXMP1-L gene in X-ALD
patients and facilitate the analysis of PXMP1-L function.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
We and others have recently reported the cloning of the full
length cDNA of peroxisomal membrane protein-1-like protein
(PXMP1-L, synonyms: PMP69, P70R) [1,2], a novel human
membrane protein which belongs to the superfamily of inte-
gral membrane transporter proteins containing an ATP bind-
ing cassette (ABC transporter). PXMP1-L is localized within
the peroxisomal membrane. Members of the ABC transporter
superfamily are involved in the transport of a variety of sub-
strates across biological membranes [3]. Mammalian examples
include the cystic ¢brosis transmembrane conductance regula-
tor (CFTR), the multiple drug resistance proteins (MDR1 and
MDR2), the retinal ABC transporter (ABCR) [4] responsible
for Stargardt’s disease, the transporters of antigen processing
TAP1 and TAP2 [5] and many others. Three other members
of the family have been located within the peroxisomal mem-
brane: the adrenoleukodystrophy protein (ALDP) [6], the per-
oxisomal protein 70 (PMP70) [7,8] and the adrenoleukodys-
trophy-related protein (ALDRP) [9,10]. Defects in the ALD
gene are the underlying cause of adrenoleukodystrophy
(ALD; McKusick 300100), an X-chromosomal recessively in-
herited demyelinating disorder of the nervous system with
marked heterogeneity of clinical manifestations even between
a¡ected individuals carrying the same mutation. ALDP is
likely to be involved in the peroxisomal transport or catabo-
lism of very long chain fatty acids (VLCFA; sC22) since
elevated VLCFA in plasma and tissues are the biochemical
hallmark of all forms of X-ALD. It has been proposed that
ALDP might be a transporter translocating VLCFA into the
peroxisome, the exclusive site of L-oxidation of VLCFA [11].
Mutations in the PMP70 gene have been associated with some
forms of Zellweger syndrome, a heterogeneous group of per-
oxisome assembly disorders [12,13], although recently doubts
have been raised whether PMP70 is indeed a Zellweger gene
[14]. The function of ALDRP, the protein most highly homol-
ogous to ALDP, is also unknown. All known peroxisomal
ABC transporters conform to the model of an ABC half-
transporter, requiring a partner half-transporter molecule (ei-
ther as a homodimer or a heterodimer) to form a functional
transporter. In Saccharomyces cerevisiae two di¡erent perox-
isomal ABC transporters (Pat1 and Pat2) have been demon-
strated to associate with each other and to be involved in the
import of fatty acids [15^17]. It is currently not known in
which way the four human peroxisomal ABC half-transport-
ers form functional complexes nor which substrates are trans-
ported. In the present work we report the detailed genomic
organization of the human PXMP1-L gene including the se-
quence immediately upstream of the transcriptional start, sev-
eral transcript variants and data on cytogenetic mapping of
the PXMP1-L gene.
2. Materials and methods
2.1. Genomic structure analysis
A human genomic DNA library generated with the pCYPAC2
vector and genomic DNA derived from cultured skin ¢bro-
blasts with an average insert size of approximately 100 kb [18] was
screened with a 793-bp human PXMP1-L cDNA probe. This probe
was ampli¢ed with primers P1f (5P-GGGCAGCTTCGGGA-
GACGCTTCTGG) and P1r (5P- GAAAGAACCCAAAGGGTT-
CAG). The oligonucleotide primer P1r is located in intron 17 which
is present on a fraction of PXMP1-L transcripts. The probe was
[K-32P]dATP-labeled by random priming and a positive clone
(LLNLP704B17234Q13) was isolated (Screening Service of the Re-
source Center of the German Human Genome Project Heidelberg/
Berlin) [19]. Southern blot analysis of EcoRI, HindIII and XbaI di-
gests with the same probe con¢rmed the presence of PXMP1-L-spe-
ci¢c fragments. Genomic fragments containing complete introns were
PCR-ampli¢ed from pCYPAC2-DNA templates using cDNA-derived
oligonucleotide primers. Template preparation was performed by ion-
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exchange columns (Qiagen midiprep) according to the manufacturer’s
protocol for P1-derived constructs. PCR ampli¢cation was performed
using the Expand Long Template system (Boehringer Mannheim). To
estimate intron sizes the PCR products were separated on 0.7% agar-
ose gels. These products were directly sequenced without further sub-
cloning from either end by the £uorescent dideoxy dye terminator
method on an ABI 377 sequencer using the ampli¢cation primers.
A fragment containing the region immediately upstream of the
transcriptional start was subcloned into the pcDNA3 vector (Invitro-
gen) from an XbaI restriction endonuclease digest of the pCYPAC2
clone LLNLP704B17234Q13 containing the entire PXMP1-L gene.
The fragment size was determined by non-radioactive Southern blot
analysis using a digoxigenin-labeled probe derived from exon 1 (DIG
Probe Synthesis Kit, Boehringer Mannheim). This probe was ampli-
¢ed from a RACE-PCR product subcloned into the pGemT-easy
vector using a T7 vector oligonucleotide primer and an exon 1-speci¢c
reverse primer. Transfer of pCYPAC-2 XbaI fragments onto nylon
membranes was performed by an alkaline capillary method (Turbo-
blotter, Schleicher and Schuell) according to the manufacturer. Hy-
bridization and chemoluminescent detection by an alkaline phospha-
tase-labeled anti-digoxigenin antibody and the substrate CDP-Star
(Boehringer Mannheim) followed the manufacturer’s protocol. The
presence of PXMP1-L-speci¢c DNA in the resulting subclones was
con¢rmed by dot blot analysis using the same exon 1-speci¢c probe.
2.2. Transcript variant analysis
In order to investigate tissue speci¢c splicing of a transcript lacking
exon 3 total RNA was prepared from human tissues using RNAzol
(Biozol). RT-PCR ampli¢cation from random-primed cDNA from a
variety of human tissues was performed with oligonucleotide primers
PF (5P-GTTCCTGCAGATACTGAAGG-3P) and PR (5P-GGTG-
CTCAGTGAGGTCCTTCC-3P) £anking exon 3. Amplitaq Gold
(Perkin Elmer) was used for PCR ampli¢cation. The PCR products
were separated on a 1.6% agarose gel and bands were visualized by
ethidium bromide staining.
2.3. Fluorescence in situ hybridization (FISH) analysis
Human metaphase cells were prepared from phytohemagglutinin-
stimulated peripheral blood lymphocytes according to standard pro-
cedures. FISH was performed using pCYPAC2-DNA from clone
LLNLP704B17234Q13 which contained the complete PXMP1-L
gene. pCYPAC2-DNA was labeled with biotin-14-dUTP (Life Tech-
nologies) by nick-translation and preannealed with Cot-1 DNA (Life
Technologies). Detection and visualization was achieved using the
avidin-£uorescein isothiocyanate/antiavidin antibody system described
elsewhere [20,21] and chromosomes were identi¢ed by staining with
4,6-diamino-2-phenylindole dihydrochloride (DAPI).
3. Results
3.1. Characterization of the region upstream from the
transcriptional start
A 3.3-kb genomic DNA fragment resulting from an XbaI
restriction digest was isolated by hybridization with an exon
1-speci¢c cDNA probe and subcloned. This fragment yielded
1832 kb of sequence immediately upstream from the 5P end of
the transcript. The transcriptional start can be expected at or
at least very close to the 5P cDNA end we have previously
reported [1] since the sequenced cDNA length corresponds
well to the signal size in Northern blot analysis. Fig. 1 shows
the putative promoter region. A TATA box was not identi-
¢ed. Three Alu repetitive elements were identi¢ed including a
tandem Alu formation at the 5P end of this region. A high GC
content (57%) was observed in the region from position 3305
to +89 which includes exon 1. The 89 bp of exon 1 including
the coding portion of exon 1 demonstrate a GC content of
72%. These ¢ndings are consistent with a housekeeping char-
acter of PXMP1-L also re£ected by its ubiquitous expression
[1]. Four putative Sp1 binding sites were identi¢ed at positions
316 to 321, 3355 to 3360, 3413 to 3418 and 31136 to
31140. Analysis of the putative promoter region did not re-
veal apparent peroxisome proliferator responsive elements
(PPRE) [22^24]. Such an element may, however, theoretically
be positioned further upstream [22].
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Fig. 1. The putative promoter region of the human PXMP1-L gene. A 1832-bp fragment immediately upstream of the transcriptional start re-
sulting from an XbaI restriction digest contains three Alu repetitive elements including a tandem Alu formation at the 5P end. Non-repetitive
sections are indicated by bold lines. Potential Sp1 binding sites are indicated by arrows.
Fig. 2. Genomic organization of the human PXMP1-L gene. Closed boxes represent exons. Intron and exon sizes (in bp) are indicated. Num-
bers in parentheses indicate the coding sequence of exons that also contain non-coding portions. The human PXMP1-L gene extends over
16.0 kb and consists of 19 exons and 18 introns.
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3.2. Determination of the exon-intron structure and Southern
blot analysis
The genomic organization was determined by PCR ampli-
¢cation of genomic fragments with cDNA-derived primers
using a pCYPAC2 clone containing the entire PXMP1-L
gene. Overlapping fragments spanning the complete coding
region were generated and sequenced. Comparison of the ob-
tained sequence with the cDNA sequence revealed that the
PXMP1-L gene consists of 19 exons and 18 introns (Fig. 2).
The last exon is the largest one containing 545 bp, if the
predominant transcript derived from utilization of the up-
stream polyadenylation signal is considered (1083 bp if the
more downstream alternative polyadenylation signal is
used). All other exons range in length between 39 bp and
210 bp. All exon-intron boundaries conform to the GT-AG
rule. We have fully sequenced 11 introns (introns 3^6, 8^10,
12^15, 17) and determined the exon-£anking intronic sequen-
ces of all other introns. The approximate sizes of introns not
fully sequenced were determined by agarose gel electrophore-
sis of corresponding PCR products. The total size of the
PXMP1-L gene is approximately 16.0 kb (Fig. 2).
Southern blot analysis was performed with the partial
cDNA probe described above using EcoRI, HindIII and
XbaI digests of human genomic DNA isolated from leuko-
cytes. A 12- and a 7.7-kb fragment (EcoRI), a 4.3- and a
3.2-kb fragment (HindIII) and an 11-kb fragment (XbaI)
were observed. Corresponding restriction digests of the pCY-
PAC-2 clone containing the entire PXMP1-L gene yielded
identical fragments (data not shown).
3.3. Fluorescence in situ hybridization analysis of the
PXMP1-L gene
FISH analysis with a PXMP1-L-speci¢c probe revealed a
single signal on chromosome 14q24 (Fig. 3). This ¢nding is in
agreement with the previously reported location of a 227-bp
PXMP1-L-speci¢c cDNA fragment on a cosmid derived from
chromosome 14q24.3 (Sharma et al., unpublished entry in
NCBI/GenBank accession number N65934) and is also con-
sistent with recent ¢ndings by Shani and colleagues [2]. STS
entry A06I12 in the NCBI Human Gene Map which places a
PXMP1-L-speci¢c transcript between chromosomal markers
D14S71 and D14S76 also con¢rms this localization. These
data correct another report [4] which maps a PXMP1-L-spe-
ci¢c cDNA fragment to chromosome 14q12. Our FISH data
are consistent with PXMP1-L being a single copy gene which
is also supported by data of the Southern blot analysis.
3.4. Transcript variants
In addition to transcript variants we have previously de-
scribed [1], other transcripts resulting from alternative splicing
have been detected. Fig. 4 shows the analysis of RT-PCR
products from various tissues for a variant lacking exon 3.
This variant is present in all tissues examined. Additionally
a variant containing the complete 506-bp intron 13 has been
detected. The knowledge of the genomic structure allows as-
signment of previously described variants to speci¢c splice
sites. Table 1 lists all known transcript variants of PXMP1-
L including those resulting from alternative polyadenylation.
4. Discussion
PXMP1-L is the fourth known member of the peroxisomal
subgroup of ABC half-transporters including ALDP, ALDRP
and PMP70. The genomic organization of PXMP1-L di¡ers
signi¢cantly from other peroxisomal ABC transporters The
ALD gene has been reported to contain 10 exons [25], the
FEBS 20121 17-4-98
Fig. 3. FISH analysis of the human PXMP1-L gene using PAC
LLNLP704B17234Q13 containing the complete PXMP1-L gene.
Fluorescent signals on DAPI-stained chromosomes are indicated by
arrows. A single signal is detected on chromosome 14q24.
Fig. 4. Tissue analysis of the splice variant vex-3 lacking exon 3.
RT-PCR analysis using cDNA-derived oligonucleotide primers
£anking exon 3. The 287-bp product represents the transcript in-
cluding exon 3, the 159-bp product represents the transcript lacking
exon 3. vex-3 is present in all tissues examined.
Table 1
Transcript variants of the PXMP1-L gene
Variant Description Position in cDNA (bp)
vex-3 missing exon 3 208^336
vex-4 missing exon 4 337^476
+intron 13 505-bp intron 13 not spliced 1470
+intron 18 171-bp intron 18 not spliced 1803
up polyA upstream (predominant) poly(A) tail 2351
Splice variants and transcripts arising from alternative polyadenylation as described previously are included. The positions in relation to the cDNA
sequence refer to NCBI/GenBank entry AF009746.
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PMP70 gene consists of 22 exons (Jutta Gaºrtner, personal
communication). Despite the di¡erent total exon number in
a comparison between PXMP1-L and PMP70, individual
exon-intron boundaries were found in corresponding segments
of the aligned cDNA sequences. Exon 10 of PXMP1-L cor-
responds to exon 14 of PMP70. The exon-intron boundary of
exon/intron 2 of PXMP1-L corresponds to the boundary of
exon/intron 4 of PMP70. This is in contrast to the relation
between the genomic structures of the ALD and ALDR genes
which are very similar (Holzinger et al., unpublished). These
data may suggest an ancient divergence time of PXMP1-L
from ancestor ABC transporters and a more recent duplica-
tion of a peroxisomal ABC transporter to result in ALD and
ALDR genes.
The genomic organization data allow the assignment of
previously reported transcript variants to alternative splicing
events of speci¢c exons and introns. The splice variant result-
ing from the loss of a 140-bp exon [1] was determined to
involve exon 4, the variant resulting from retention of an
intron to involve intron 18. In this article we describe an
additional splice variant resulting from the loss of exon 3
(Fig. 4) as well as a variant containing the complete 506-bp
intron 13. A functional role of any of these splice variants is,
however, unlikely because they all result in frame shifts lead-
ing to premature termination.
The human PXMP1-L gene is localized on chromosome
14q24.3. In contrast to clustering of functionally related
ABC half-transporters such as the transporters of antigen
processing TAP1 and TAP2 [26], all human peroxisomal
ABC transporters cloned to date are localized on di¡erent
chromosomes (ALD: Xq28, ALDR: 12q12, PMP70: 1p22^
p21). Therefore, the chromosomal localization does not allow
any speculation on the nature of interaction between perox-
isomal ABC transporters. The chromosomal locus 14q24.3
has not been linked to any known peroxisomal disease. This
locus has received intense medical interest since it contains the
AD3 gene, defects of which are associated with early-onset
Alzheimer disease (Alzheimer’s Disease Collaborative Group,
1995).
Peroxisomal ABC transporters are of particular clinical in-
terest since defects of the ALD gene are the primary cause of
adrenoleukodystrophy [6]. Biochemically, X-linked adrenoleu-
kodystrophy represents a defect of very long chain fatty acid
L-oxidation thought to be due to impaired import of the sub-
strate. The function of the other peroxisomal ABC transport-
ers is unknown, a possible involvement in fatty acid L-oxida-
tion is purely speculative. PXMP1-L is a candidate
heterodimer partner of one or more of these other peroxiso-
mal membrane proteins. The only two yeast peroxisomal ABC
transporters Pat1 and Pat2, which are involved in functions
related to fatty acid oxidation, interact with each other [15^
17]. Homodimerization as well as tissue-dependent dimeriza-
tion with various partners in order to ful¢l di¡erent transport
functions are also conceivable [2]. The homology to putative
lipid transporters (ALDP, Pat1, Pat2) might be viewed as a
support of the speculation that PMP70 and PXMP1-L might
also take part in lipid translocation. The four peroxisomal
transporters and possible heterodimer combinations might
constitute a transport system for various lipids or other sub-
strates. The comparison of temporo-spatial expression and
inducibility by hypolipidemic drugs [27] of ALDP, PMP70
and ALDR is ^ if interaction occurs ^ best interpreted as
that there is no obligatory exclusive dimer formation of any
two of these proteins.
A role of PXMP1-L in the biogenesis of peroxisomes can-
not be totally excluded. The only link to an involvement of
PXMP1-L in peroxisome assembly, however, is weak evidence
that a few patients with peroxisomal biogenesis defects (Zell-
weger syndrome) carry mutations in the PMP70 gene ^ the
closest human homolog of PXMP1-L [12]. This hypothesis is
also unlikely in the light of the high conservation of perox-
isome assembly between yeast and human [13]. The only per-
oxisomal ABC transporters in S. cerevisiae (Pat1 and Pat2)
are apparently not involved in peroxisome biogenesis [15^17].
Functional studies including protein-protein interaction ex-
periments are required to determine whether and in what
combinations human peroxisomal ABC transporters form
functional complexes. If PXMP1-L plays a role as a modi¢er
gene of adrenoleukodystrophy, sequence analysis of the
PXMP1-L gene in a¡ected brothers showing di¡erent clinical
phenotypes should reveal variants associated with the severity
of the disease. The data presented in this article will be useful
tools towards clarifying the yet unknown function of PXMP1-
L.
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